Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?

Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non‐injectors in patterns of mephedrone use and psyc...

Full description

Saved in:
Bibliographic Details
Published in:Human psychopharmacology 2015-07, Vol.30 (4), p.233-243
Main Authors: Kapitány-Fövény, Máté, Mervó, Barbara, Kertész, Máté, Corazza, Ornella, Farkas, Judit, Kökönyei, Gyöngyi, Urbán, Róbert, Demetrovics, Zsolt
Format: Article
Language:English
Subjects:
4-methylmethcathinone
Adult
Drug Administration Routes
Female
Humans
injecting
Male
mephedrone
patterns of use
Propiophenones - administration & dosage
Propiophenones - toxicity
Psychiatric Status Rating Scales
psychiatric symptoms
Regression Analysis
Self Report
Substance-Related Disorders - epidemiology
Substance-Related Disorders - physiopathology
Substance-Related Disorders - psychology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non‐injectors in patterns of mephedrone use and psychiatric symptom status. Methods One hundred and forty‐five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory. Results Majority of users received mephedrone from acquaintances and used it in discos/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4%). Injectors (11%) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5%) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio. Conclusions Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning. Copyright © 2015 John Wiley & Sons, Ltd.
ISSN:0885-6222
1099-1077
DOI:10.1002/hup.2490